Attracted to the tumor site and regulated by the action of IL-8, EVs and other chemotactic factors, TANs can interfere with different antitumoral treatments not only by releasing EVs but also by secreting specific factors as well as by undergoing NETosis. The gene discussed is CXCL8; the disease is neoplasm.